THE INHIBITORY EFFECT OF MAGNOLOL ON CUTANEOUS PERMEABILITY IN MICE IS PROBABLY MEDIATED BY A NONSELECTIVE VASCULAR HYPOREACTIVITY TO MEDIATORS

被引:27
作者
WANG, JP
RAUNG, SL
CHEN, CC
KUO, JS
TENG, CM
机构
[1] NATL RES INST CHINESE MED,TAIPEI,TAIWAN
[2] NATL TAIWAN UNIV,COLL MED,INST PHARMACOL,TAIPEI,TAIWAN
关键词
D O I
10.1007/BF00167245
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study, we demonstrated the inhibitory effect of magnolol on the plasma leakage in passive cutaneous anaphylactic (PCA) reaction, neurogenic inflammation, dorsal skin and ear edema in mice. Hind-paw skin plasma extravasation caused by antidromic stimulation of the saphenous nerve was reduced in mice pretreated with magnolol, diphenydramine or methysergide, but not with indomethacin. Ear edema formation in the PCA reaction was reduced by magnolol in dose-dependent manner. In addition, histamine-, serotonin-, compound 48/80-, bradykinin- and substance P-induced ear edema in mice was also suppressed by magnolol. A dose- and time-dependency of the inhibitory effect of magnolol was demonstrated in histamine- and compound 48/80-induced dorsal skin edema. The maximal inhibitory effect produced by a single dose of magnolol (I 0 mg/kg) persisted for 1 h, and significant suppression lasted for at least 3 h. In compound 48/80-pretreated mice, the histamine content of the ear was greatly reduced. Bradykinin- and substance P-induced ear edema in compound 48/80-pretreated mice was less severe than that seen in normal mice, but was still significantly reduced by magnolol pretreatment. Moreover, the inhibitory effect of magnolol was more marked than that of diphenhydramine combined with methysergide. These results suggest that the inhibitory effect of magnolol on local edema formation probably occurs through a nonselective inhibition on vascular tissue to prevent the permeability change caused by various mediators.
引用
收藏
页码:663 / 669
页数:7
相关论文
共 48 条
[1]  
BARRETT AJ, 1972, LYSOSOMES LABORATORY, P118
[2]  
DOBBINS DE, 1982, MICROCIRCULATION, V2, P127
[3]  
FLORJANCIRMAN T, 1983, AGENTS ACTIONS, V13, P138
[4]   NEUROGENIC INFLAMMATION [J].
FOREMAN, JC ;
JORDAN, CC .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1984, 5 (03) :116-119
[5]  
FUJITA M, 1972, CHEM PHARM BULL, V20, P212, DOI 10.1248/cpb.20.212
[6]  
GABBIANI G, 1970, P SOC EXP BIOL MED, V135, P447
[7]   DECREASE OF SUBSTANCE-P IN PRIMARY AFFERENT NEURONS AND IMPAIRMENT OF NEUROGENIC PLASMA EXTRAVASATION BY CAPSAICIN [J].
GAMSE, R ;
HOLZER, P ;
LEMBECK, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1980, 68 (02) :207-213
[8]  
GARRISON JC, 1991, PHARMACOL BASIS THER, P575
[9]  
HADDY FJ, 1976, CARDIOVASCULAR PHYSL, V2, P63
[10]   IMPROVED FLUOROMETRIC ASSAY OF HISTAMINE - CONDENSATION WITH O-PHTHALALDEHYDE AT -20 DEGREES-C [J].
HAKANSON, R ;
RONNBERG, AL .
ANALYTICAL BIOCHEMISTRY, 1974, 60 (02) :560-567